Documentos relacionados

1. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
2. Can systematic reviews contribute to regulatory decisions?
3. What impact could the legalisation of recreational cannabis have on the health of the UK? Lessons from the rest of the world.
4. Home cannabis cultivation in the United States and differences by state-level policy, 2019-2020.
5. Taking the cat-and-mouse game to the next level: different perspectives on the introduction of the German New Psychoactive Substances Act.
6. Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine.
7. Non-medical cannabis in North America: an overview of regulatory approaches.
8. Linkage of Safety Information to Regulatory Action.
9. Regulators need to rethink restrictions on cannabis research.
10. The rise of new psychoactive substances and psychiatric implications: A wide-ranging, multifaceted challenge that needs far-reaching common legislative strategies.